Quercetin promotes functional recovery following acute spinal cord injury

Journal of Neurotrauma

Volumn 20, Issue 6, 2003, Pages 583-591

  Schultke E ^a   Kendall, E ^a   Kamencic, H ^a   Ghong, Z ^a   Griebel, R W ^a   Juurlink, Bernhard H J ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Functional recovery; Iron chelation; MRI; Neurotrauma; Rat; Spinal cord

Indexed keywords

FERROUS ION; FLAVONOID; IRON CHELATING AGENT; QUERCETIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DOSE RESPONSE; DRUG MECHANISM; IRON CHELATION; LAMINECTOMY; MALE; MOTOR PERFORMANCE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; SPINAL CORD INJURY; WALKING;

EID: 17344374599     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/089771503767168500     Document Type: Article

References (71)

1. AFANAS'EV, I.B., DOROZHKO, A.I., BRODSKI, A.V., et al. (1989). Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem. Pharm. 38, 1763-1769.
2. BASSO, D.M., BEATTIE, M.S., and BRESNAHAN, J.C. (1995). A sensitive and reliable locomotor rating scale for open field tests in rats. J. Neurotrauma 12, 1-21.
3. BASSO, D.M., BEATTIE, M.S., BRESNAHAN, J.C., et al. (1996). MASCIS evaluation of open field locomotor scores: effects of experience and teamwork on reliability. J. Neurotrauma 13, 343-359.
4. BEATTIE M.S., FAROOQUI A.A., and BRESNAHAN J.C. (2000). Review of current evidence for apoptosis after spinal cord injury. J. Neurotrauma 17, 915-925.
5. BEN-HUR, E., ROSENTHAL, I., and GRANOT Y. (1993). Inhibition of phtalocyanine-sensitized photohemolysis of human erythrocites by quercetin. Photochem. Photobiol. 57, 984-988.
6. BRADLEY, W.G. (1993). MR appearance of hemorrhage in the brain. Radiology 189, 15-26.
7. BRAUGHLER, J.M., and HALL, E.D. (1992). Involvement of lipid peroxidation in CNS injury. J. Neurotrauma 9, Suppl 1, S1-S7.
8. BREWER, K.L., BETHEA, J.R., and YEZIERSKI, R.P. (1999). Neuroprotective effects of interleukin-10 following exitotoxic spinal cord injury. Exp. Neurol. 159, 484-493.
9. CARLSON, S.L., PARRISH, M.E., SPRINGER, J.E., et al. (1998). Acute inflammatory response in spinal cord injury following impact injury. Exp. Neurol. 152, 77-88.
10. CHATZIPANTELI, K., GARCIA, R., MSRCILLO, A.E., et al. (2002). Temporal and segmental distribution of constitutive and inducible nitric oxide synthases after traumatic spinal cord injury: effect of aminoguanidine treatment. J. Neurotrauma 19, 639-651.
11. CHENG, F.L., and BREEN, K. (2000). On the ability of four flavonoids, bacilein, luteolin, narigenin, and quercetin, to suppress the fenton reaction of the iron-ATP complex. BioMetals 13, 77-83.
12. COMPORTI, M., SIGNORINI, C., BUONOCORE, G., et al. (2002). Iron release, oxidative stress and erythrocyte ageing. Free Radic. Biol. Med. 32, 568-576.
13. CONSTANTINI, S., and YOUNG, W. (1994). The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats. J. Neurosurg. 80, 97-111.
14. COTELLE, N., BERNIER, J.-L., CATTEAU, J.-P., et al. (1996). Anti-oxidant properties of hydroxy-flavones. Free Radic. Biol. Med. 20, 35-43.
15. CROWE, M.J., BRESNAHAN, J.C., SHUMAN, S.L., et al. (1997). Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat. Med. 3, 73-76.
16. CUEVAS, P., and CARCELLER, F. (2001). Therapeutic implications of fibroblast growth factors in traumatic spinal cord injury. Neurol. Res. 23, 207-209.
17. FAROOQUE, M., ISAKSSON, J., and OLSSON, Y. (1999). Improved recovery after spinal cord trauma in ICAM-1 and P-selectin knockout mice. Neuroreport 10, 131-134.
18. FEHLINGS, M.G., and BRACKEN M.B. (2001). Summary statement: the Sygen(GM-1 ganglioside) clinical trial in acute spinal cord injury. Spine 26, S99-S100.
19. FEHLINGS, M.G., and SEKHON, L.H.S. (2000). Cellular, ionic and biomolecular mechanisms of the injury process, in: Contemporary Management of Spinal Cord Injury: From Impact to Rehabilitation. C.H. Tator and E.C. Benzel (eds), American Association of Neurological Surgeons: New York, pps. 35-50.
20. FERNANDEZ, M.T., MIRA, M.L., FLORENCIO, M.H., et al. (2002). Iron and copper chelation by flavonoids: an electrospray mass spectrometry study. J. Inorganic Biochem. 92, 105-111.
21. FERRALI, M., SIGNORINI, C., and CICCOLI, L. (1992). Iron release and membrane damage in erythrocytes exposed to oxidizing agents, phenylhydrazine, divicine and isouramil. Biochem. J. 285, 295-301.
22. FERRANDIZ, M.L., and ALCARAZ, M.J. (1991). Anti-inflammatory activity and inhibition of arachidonic acid metabolism by flavonoids. Agents Actions 32, 283-288.
23. GAETANI, P., PASQUALIN, A., RODRIGUEZ, Y., BAENA, R., et al. (1998). Oxidative stress in the human brain after subarachnoid hemorrhage. J. Neurosurg. 89, 748-754.
24. GALEY, J.-B. (1997). Potential use of iron chelators against oxidative damage. Adv. Pharmacol. 38, 167-203.
25. GRIFFTTHS, L.A., and BARROW, A. (1972). The fate of orally and parenterally administered flavonoids in the mammal. Angiologica 9, 162-174.
26. GUTTERIDGE, J.M.C., ROWLEY, D.A., and HALIWELL, B. (1981). Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Biochem. J. 199, 263-265.
27. HALL, E.D. (1995). Inhibition of lipid peroxidation in central nervous system trauma and ischemia. J. Neurol. Sci. 134, Suppl, 79-83.
28. HALL, E.D. (2001). Pharmacological treatment of acute spinal cord injury: how do we build on past success? J. Spinal Cord Med. 24, 142-146.
29. HALLIWELL, B., and GUTTERIDGE, J.M.C. (1989). Free Radicals in Biology and Medicine. Clarendon Press: Oxford.
30. HIDER, R.C., EPIMOLU, O., SINGH, S., et al. (1994). Iron chelator design, in: Progress in Iron Research. C. Hershko, A.M. Konijn, and P. Aisen (eds), Plenum Press: New York, pps. 343-349.
31. HOLLMAN, P.C., van der GAAG, M., MENGELERS, M.J., et al. (1996). Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Radic. Biol. Med. 21, 232-235.
32. HORKY, L.L., PLUTARD, R.M., BOOCK, R.J., et al. (1998). Role of ferrous iron chelator 2,2′-dipyridyl in preventing delayed vasospasm in a primate model of subarachnoid hemorrhage. J. Neurosurg. 88, 298-303.
33. HUK, I., BROKOVYCH, V., NANOBASH, VILI J., et al. (1998). Bioflavonoid quercetin scavenges superoxide and increases nitric oxide concentration in ischemia-reperfusion injury: an experimental study. Br. J. Surg. 85, 1080-1085.
34. HURLBERT, R.J. (2001). The role of steroids in acute spinal cord injury. An evidence-based analysis. Spine 26, S39-S46.
35. JUURLINK, B.H.J., and PATERSON, P.G. (1998). Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological interventions and nutritional management strategies. J. Spinal Cord Med. 21, 309-334.
36. KAMENCIC, H., GRIEBEL, R.W., LYON, A., et al. (2001). Promoting glutathione synthesis following spinal cord trauma decreases secondary damage and promotes retention of function. FASEB J. 15, 243-250.
37. KOC, R.K., AKDEMIR, H., KARAKUCUK, E.I., et al. (1999). Effect of methylprednisolone, tirilazad mesylate and vitamin E on lipid peroxidation after experimental spinal cord injury. Spinal Cord 37, 29-32.
38. KOSZYCA, B., MANAVIS, J., CORNISH, R.J., et al. (2002). Patterns of immunocytochemical staining for ferritin and transferrin in the human spinal cord following traumatic injury. J. Clin. Neurosci. 9, 298-301.
39. MALLORY, F.B. (1961). Pathological Technique, 3rd ed. Noble Offset Printers, Inc., NY.
40. MATZ, P.G., FUJIMURA, M., and CHAN, P.H. (2000). Subarachnoid hemolysate produces DNA fragmentation in a pattern similar to apoptosis in mouse brain. Brain Res. 858, 312-319.
41. MIDDLETON, E., and KANDASWAMI, C. (1992). Effects of flavonoids on immune and inflammatory cell functions. Biochem. Pharm. 43, 1167-1179.
42. MOREL I., LESCOAT G., COGREL P., et al. (1993). Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on ironded rat hepatocyte cultures. Biochem. Pharm. 45, 13-19.
43. NOCKELS, R., and YOUNG, W. (1992). Pharmacologic strategies in the treatment of experimental spinal cord injury. J. Neurotrauma 9, Suppl 1, S211-S217.
44. PELZER, L.E., GUARDIA, T., OSVALDO JUAREZ, A., et al. (1998). Acute and chronic antiinflammatory effects of plant flavonoids. Farmaco 53, 421-424.
45. POPOVICH P.G., GUAN Z., WEI P., et al. (1999). Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp. Neurol. 158, 351-365.
46. RABCHEVSKY, A.G., FUGACCIA, I., FLETCHER-TURNER, A., et al. (1999). Basic fibroblast growth factor (bFGF) enhances tissue sparing and functional recovery following moderate spinal cord injury. J. Neurotrauma 16, 870-830.
47. RABCHEVSKY, A.G., FUGACCIA, I., FLETCHER-TURNER, A., et al. (2000). Basic fibroblast growth factor (bFGF) enhances tissue sparing and functional recovery following severe spinal cord injury in the rat. Exp. Neurol. 164, 280-291.
48. RATTY, A.K., and DAS N.P. (1988). Effects of flavonoids on nonenzymatic lipid peroxidation: structure-activity relationship. Biochem. Med. Metab. Biol. 39, 69-79.
49. REGAN, R.F., and GOU Y. (1998). Toxic effect of hemoglobin on spinal cord neurons in culture. J. Neurotrauma 15, 645-653.
50. RIVLIN, A.S., and TATOR, C.H. (1977). Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J. Neurosurg. 47, 577-581.
51. RIVLIN, A.S., and TATOR C.H. (1978). Effect of duration of acute spinal cord compression in a new acute injury model in the rat. Surg. Neurol. 10, 38-43.
52. ROMANOVA, D., VACHALKOVA, A., CIPAK, L., et al. (2001). Study of antioxidant effect of apigenin, luteolin and quercetin by DNA protective method. Neoplasma 48, 104-107.
53. SAIJA, A., SCALESE, M., LANZA, M., et al. (1995). Flavonoids as antioxidant agents: importance of their actions with biomembranes. Free Radic. Biol. Med. 19, 481-486.
54. SCHÜLTKE, E., and HARRUFF, R.C. (2000). Immunocytochemistry in spinal cord injury: S-100 expression in human autopsy material. Soc. Neurosci. Abstr. 27, 516.
55. SEKHON, L.H., and FEHLINGS, M.G. (2001). Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine 26, Suppl 24, S2-S12.
56. SESTILI, P., GUIDARELLI, A., DACHA, M., et al. (1998). Quercetin prevents DNA single strand breakage and cytotoxicity caused by tert-butylhydroperoxide: free radical scavenging versus iron chelating mechanism. Free Radic. Biol. Med. 25, 196-200.
57. SHUMAN, S.L., BRESNAHAN, J.C., and BEATTIE, M.S. (1997). Apoptosis of microglia and oligodendrocytes after spinal cord contusion injury. J. Neurosci Res. 50, 798-808.
58. SOBOTTKA, A.M., WERNER, W., BLASCHKE, G., et al. (2000). Effect of flavonoid derivatives on the carrageenin-induced paw edema in the rat and inhibition of cyclooxygenase-1 and 5-lipoxygenase in vitro. Arch. Pharm. (Weinheim) 333, 205-210.
59. SORATRA, Y., TAKAHAMA, U., and KIMURA, M. (1984). Protective effect of quercetin and rutin on photosensitized lysis of human erythrocites in the presence of hematoporphyrin. Biochim. Biophys. Acta 799, 313-317.
60. SUGIHARA, N., ARAKAWA, T., OHNISHI, M., et al. (1999). Anti- and pro-oxidative effects of flavonoids on metal-induced hyperoxide-dependent lipid peroxidation in cultured hepatocytes loaded with α-linoleic acid. Free Radic. Biol. Med. 27, 1313-1323.
61. TAOKA Y., OKAJIMA K., UCHIBA M., et al. (1997). Role of neutrophils in spinal cord injury in the rat. Neuroscience 79, 1177-1182.
62. TATOR, C.H. (1991). Review of experimental spinal cord injury with emphasis on the local and systemic circulatory effects. Neurochirurgie 37, 291-302.
63. TATOR, C.H., and FEHLINGS, M.G. (1991). Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J. Neurosurg. 75, 25-26.
64. TATOR, C.H., and KOYANAGI, I. (1997). Vascular mechanisms in the pathophysiology of human spinal cord injury. J. Neurosurg. 86, 483-492.
65. THOMPSON, J.H. (1966). Radio-iron absorption in the rat after phenyl hydrazine induced anemia. Ir. J. Med. Sci. 484, 127-132.
66. VAN ACKER, S.A.B.E., VAN DEN BERG, D.-J., TROMP, M.N.J.L., et al. (1995). Structural aspects of antioxidant activity of flavonoids. Free Radic. Biol. Med. 20, 331-342.
67. 2+ ions. Membr. Cell. Biol. 14, 47-56.
68. VYMAZAL, J., BROOKS, R.A., BAUMGARNER, C., et al. (1996). The relation between brain iron and NMR relaxation times: an in vitro study. Magn. Reson. Med. 35, 56-61.
69. WEIDNER N., GRILL R.J., and TUSZYNSKI M.H. (1999). Elimination of basal lamina and the collagen "scar" after spinal cord injury fails to augment corticospinal tract regeneration. Exp. Neurol. 160, 40-50.
70. XU, J., FAN, G., CHEN, S., et al. (1998). Methylprednisolone inhibition of TNF-alpha expression and NF-kappabeta activation after spinal cord injury in rats. Mol. Brain Res. 59, 135-142.
71. YONG, C., ARNOLD, P., ZOUBINE, M.N., et al. (1998). Apoptosis in cellular compartments of rat spinal cord after severe contusion injury. J. Neurotrauma 15, 459-471.